Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | IL1R1 | P14778 | 1/20 | 0.30 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15802094 | 0.93 | KDM4E (0.34) | KDM4EL3MBTL1ATMRXFP1 | |
| SCHEMBL20426182 | 0.88 | L3MBTL1 (0.39) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL15801938 | 0.88 | — | — | |
| SCHEMBL20426242 | 0.87 | KDM4E (0.36) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL20426239 | 0.87 | L3MBTL1 (0.38) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL20426231 | 0.85 | L3MBTL1 (0.39) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL15632153 | 0.85 | KDM4E (0.33) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL15801650 | 0.84 | KDM4E (0.31) | KDM4EL3MBTL1ATM | |
| SCHEMBL16357554 | 0.84 | KDM4E (0.36) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 | |
| SCHEMBL2754622 | 0.84 | L3MBTL1 (0.44) | KDM4EL3MBTL1ATMRXFP1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | DOOSAN CORPORATION (KR) | 2018-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10038146-B2 | Organic light-emitting compound and organic electroluminescent device using same | IDO1, IDO2, KYNU | KDM4E 1494/4885L3MBTL1 464/4885ATM 4017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.